Opportunity Information: Apply for PA 07 031

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "New Approaches to Arrhythmia Detection and Treatment (STTR R41/R42)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837 Cardiovascular Diseases Research.
  • This funding opportunity was created on Jan 26, 2009 and posted on Nov 3, 2006.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Small businesses Others (see text field entitled Additional Information on Eligibility for clarification).
  • Foreign institutions are not eligible to apply.
Apply for PA 07 031

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Institutes of Health (NIH) funding opportunity titled "New Approaches to Arrhythmia Detection and Treatment (STTR R41/R42)" (Funding Opportunity Number PA-07-031) supports small businesses working on new technologies and approaches to detect, monitor, and treat cardiac arrhythmias. The program is offered as a discretionary grant under the NIH cardiovascular research portfolio (CFDA 93.837, Cardiovascular Diseases Research). The intent is to move promising arrhythmia-related innovations from early feasibility work toward more advanced development, with the overall focus on practical solutions that could improve how abnormal heart rhythms are identified and managed.

This announcement uses the Small Business Technology Transfer (STTR) mechanisms, specifically R41 (Phase I) and R42 (Phase II), and it also allows Fast-Track applications that combine Phase I and Phase II in a single submission for projects that are ready to move quickly from feasibility to development. A key feature of STTR is the required collaboration between a U.S. small business concern (SBC) and a non-profit research institution, helping translate academic or institutional expertise into commercially viable medical products or services. The announcement notes it runs in parallel with a companion funding opportunity (PA-07-032) that has identical scientific scope but uses the SBIR mechanisms (R43/R44), which generally have different collaboration requirements. In practice, this means applicants should choose the mechanism that best matches their development plan and organizational structure while pursuing the same general scientific goals in arrhythmia innovation.

Eligibility is limited to U.S. small business concerns. The small business must meet all SBC criteria at the time of award for both Phase I and Phase II, as defined in the eligibility section of the full announcement. Foreign institutions are explicitly not eligible to apply. The listing also indicates "Others (see text field entitled Additional Information on Eligibility for clarification)," which typically reflects the STTR partnership structure where the applicant is the SBC, but the work is shared with an eligible U.S. research institution under the STTR rules.

There is no cost sharing or matching requirement stated for this opportunity, which is important for early-stage companies that may not have significant non-federal funds available. However, awards are not guaranteed: NIH makes clear that funding depends on the availability of funds and the receipt of a sufficient number of scientifically and technically strong applications. Like most NIH programs, this implies competitive peer review, with awards going to proposals judged meritorious relative to others in the applicant pool and aligned with program priorities.

The opportunity was posted on November 3, 2006, and later shows a creation date of January 26, 2009, with multiple receipt dates rather than a single deadline. That structure usually means the program accepted applications at several standard NIH submission cycles over its open period. The archive date is listed as January 5, 2010, indicating the announcement is no longer active, but it remains a useful reference point for understanding NIH priorities and the STTR pathway for arrhythmia-related product development during that period.

For applicants or readers looking for the authoritative details, the full announcement link is provided (http://grants.nih.gov/grants/guide/pa-files/PA-07-031.html). NIH also lists support contacts through the NIH Office of Extramural Research (OER) webmaster emails for assistance accessing or linking to the announcement (FBOWebmaster@OD.NIH.GOV), which is mainly helpful for technical access issues rather than scientific questions.

Frequently Asked Questions (FAQs)

What is the title and funding opportunity number for this NIH grant?

The opportunity is titled "New Approaches to Arrhythmia Detection and Treatment (STTR R41/R42)" and the Funding Opportunity Number is PA-07-031.

What is the main purpose of this funding opportunity?

This NIH opportunity supports small businesses developing new technologies and approaches to detect, monitor, and treat cardiac arrhythmias. The stated intent is to move promising arrhythmia-related innovations from early feasibility work toward more advanced development, with an emphasis on practical solutions that could improve how abnormal heart rhythms are identified and managed.

Which NIH funding mechanisms are used in this announcement?

The announcement uses the Small Business Technology Transfer (STTR) mechanisms: R41 (Phase I) and R42 (Phase II). It also allows Fast-Track applications that combine Phase I and Phase II in a single submission.

What do Phase I (R41) and Phase II (R42) generally represent in this program?

Based on the description provided, Phase I (R41) supports early feasibility work, while Phase II (R42) supports more advanced development work that builds on feasibility results. The overall goal is to move an innovation toward a more developed, practical product or service for arrhythmia detection or treatment.

What is a Fast-Track application in this context?

A Fast-Track application combines Phase I and Phase II into a single submission. This is intended for projects that are ready to move quickly from feasibility to development.

Who is eligible to apply?

Eligibility is limited to U.S. small business concerns (SBCs). The small business must meet all SBC criteria at the time of award for both Phase I and Phase II, as defined in the full announcement.

Are foreign institutions allowed to apply?

No. Foreign institutions are explicitly not eligible to apply under this opportunity.

Does STTR require collaboration with a research institution?

Yes. A key feature of STTR, as described, is the required collaboration between a U.S. small business concern and a non-profit research institution. The purpose of this partnership is to help translate academic or institutional expertise into commercially viable medical products or services.

Who is the official applicant under STTR: the small business or the research institution?

The applicant is the U.S. small business concern, with work shared with an eligible U.S. research institution under STTR rules. The listing also notes "Others" for eligibility, which typically reflects this partnership structure.

Is cost sharing or matching required?

No cost sharing or matching requirement is stated for this opportunity.

Is funding guaranteed if an application is submitted?

No. NIH indicates that funding depends on the availability of funds and the receipt of a sufficient number of scientifically and technically strong applications. This implies a competitive process where awards go to proposals judged meritorious relative to others and aligned with program priorities.

What NIH research area or portfolio does this opportunity fall under?

The opportunity is offered as a discretionary grant under the NIH cardiovascular research portfolio and is associated with CFDA 93.837, Cardiovascular Diseases Research.

Is there a companion announcement related to this one?

Yes. The announcement runs in parallel with a companion funding opportunity, PA-07-032, which has identical scientific scope but uses SBIR mechanisms (R43/R44).

How is the companion SBIR announcement described as different from this STTR announcement?

The companion opportunity uses SBIR mechanisms (R43/R44), which are described as generally having different collaboration requirements than STTR. Applicants are advised to choose the mechanism that best matches their development plan and organizational structure while pursuing the same overall scientific goals in arrhythmia innovation.

Are there single or multiple submission deadlines for this opportunity?

The information provided indicates multiple receipt dates rather than a single deadline. This typically means the program accepted applications across several standard NIH submission cycles while it was open.

When was this opportunity posted, and is it still active?

The opportunity was posted on November 3, 2006, and also shows a creation date of January 26, 2009. The archive date is January 5, 2010, which indicates the announcement is no longer active.

Where can applicants find the full, authoritative announcement details?

The full announcement is available at: http://grants.nih.gov/grants/guide/pa-files/PA-07-031.html

Who should be contacted for technical issues accessing or linking to the announcement?

NIH lists support contacts through the NIH Office of Extramural Research (OER) webmaster email for technical access or linking assistance: FBOWebmaster@OD.NIH.GOV

Does the listed contact address scientific or programmatic questions?

The provided description indicates the listed OER webmaster contact is mainly helpful for technical access issues rather than scientific questions.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44)

Previous opportunity: New Technology to Screen for Mild Hearing Loss in Children (STTR R41/R42)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 031

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 031) also looked into and applied for these:

Funding Opportunity
New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44) Apply for PA 07 032

Funding Number: PA 07 032
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01) Apply for PA 07 092

Funding Number: PA 07 092
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders STTR (R41/R42) Apply for PA 07 395

Funding Number: PA 07 395
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health STTR R41/R42 Apply for PA 07 423

Funding Number: PA 07 423
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health SBIR R43/R44 Apply for PA 07 424

Funding Number: PA 07 424
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Technology for Proteomics and Glycomics (SBIR R43/R44) Apply for PA 07 451

Funding Number: PA 07 451
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Technology for Proteomics and Glycomics (STTR R41/R42) Apply for PA 07 452

Funding Number: PA 07 452
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High Throughput Tools for Brain and Behavior (SBIR R43/R44) Apply for PA 08 001

Funding Number: PA 08 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High Throughput Tools for Brain and Behavior (STTR R41/R42) Apply for PA 08 002

Funding Number: PA 08 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of PET and SPECT Ligands for Brain Imaging (SBIR R43/R44) Apply for PA 08 137

Funding Number: PA 08 137
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pharmacologic Agents and Drugs for Mental Disorders (SBIR R43/R44) Apply for PA 08 142

Funding Number: PA 08 142
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Cooperative Program in Translational Research Small Business Awards (SBIR U44) Apply for PAR 08 235

Funding Number: PAR 08 235
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
State Implementation Grants for Integrated Community Systems for CSHCN Apply for HRSA 09 159

Funding Number: HRSA 09 159
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $300,000
Part D Coordinated HIV Services and Access to Research for WICY One TimeSupplemental Funds Apply for HRSA 09 143

Funding Number: HRSA 09 143
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Development, Implementation and Evaluation of Strategies to Increase Vaccination of Adolescents Affiliated with a Medical Home (U01) Apply for RFA IP 09 006

Funding Number: RFA IP 09 006
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $550,000
Evaluation of New Technology to Improve Delivery of Immunizations (U01) Apply for RFA IP 09 005

Funding Number: RFA IP 09 005
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $225,000
NCMHD Endowment Program for Increasing Research and Institutional Resources Capacity in Section 736 Health Professions Schools (NCMHD Research Endowment Fund) (S21) Apply for RFA MD 09 002

Funding Number: RFA MD 09 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Extension of the World Trade Center Registry (U50) Apply for RFA OH 09 002

Funding Number: RFA OH 09 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $12,000,000
NCMHD Research Infrastructure in Minority Institutions (P20) Apply for RFA MD 09 003

Funding Number: RFA MD 09 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Based HIV/AIDS Prevention, Care and Support Apply for USAID UGANDA RFA 617 09 005

Funding Number: USAID UGANDA RFA 617 09 005
Agency: Agency for International Development
Category: Health
Funding Amount: $22,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 031", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.